Conference Call Exclusive to NEHI Members
Scott Deitchman, MD, MPH, Chief Medical Officer, US Centers for Disease Control and Prevention's National Center for Environmental Health and the Agency for Toxic Substances and Disease Registry. In his role at CDC, Scott led CDC’s responses to several ricin incidents, the 2004/5 Asian tsunami disaster, the 2010 Deepwater Horizon oil spill, and the 2011 Fukushima Daiichi nuclear reactor emergency in. During the Haiti earthquake response in January 2010, he served as CDC’s first-ever liaison to the US military Joint Task Force in Haiti. From April 2006 to May 2007 RADM Deitchman served in the White House as the Vice President’s Medical Advisor for Homeland Security Affairs. He holds the rank of Rear Admiral in the US Public Health Service. Scott has published and spoken on a wide variety of topics in occupational safety and health and in public health preparedness for, and response to, the public health consequences of various types of disasters. His current areas of major activity include public health preparedness for radiological and nuclear disasters, and preparing public health professionals to exercise crisis leadership during public health emergencies. He has completed residency training and is board certified in two medical specialties: occupational and environmental medicine; and general preventive medicine, completing training at the Ohio State University, Northeastern Ohio Medical University, Johns Hopkins University, and the University of Cincinnati. Scott’s awards and honors include the PHS Meritorious Service Medal, Outstanding Service Medal, Commendation Medal, and Achievement Medal. He was inducted as an alumnus nominee into the Alpha Omega Alpha national medical honor society.
Jon Heinrichs, Ph.D., Associate Vice President and Segment Head, Sanofi Pasteur. Jon Heinrichs is an Associate Vice President and Segment Head in Global Project Leadership at Sanofi Pasteur in Swiftwater, PA where he leads vaccine projects in the Pre-Development and Early Development spaces. Prior to joining Sanofi, Dr. Heinrichs headed the Microbial Vaccine Research group at Merck Research Labs where he led a team of scientists developing vaccines for several bacterial pathogens including Clostridium difficile, Staphylococcus aureus, Streptococcus pneumoniae, and Chlamydia trachomatis. Dr. Heinrichs previously held positions of increasing responsibility at the biotechnology company MedImmune (now part of AstraZeneca), where he contributed to the identification of vaccine candidates for numerous bacterial pathogens, particularly S. pneumoniae. He was also involved in research on the efficacy of monoclonal antibodies for the prevention of infectious diseases and the treatment of cancer, and was head of the In Vivo Biology group. Dr. Heinrichsearned his doctoral degree in microbiology and molecular genetics from Rutgers University and the University of Medicine and Dentistry of New Jersey, by elucidating the pathogenesis of the food-borne organism Bacillus cereus, and completed a post-doctoral fellowship in the Laboratory of Bacterial Pathogenesis and Immunology at The Rockefeller University where he examined global regulation in S. aureus.